Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Usher Syndrome Type IJ and Deafness, Autosomal Recessive 48 (DFNB48) via the CIB2 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 11 | 12 |
|
OtoGenome Test for Hearing Loss (110 Genes) Laboratory for Molecular Medicine Mass General Brigham Personalized Medicine United States | 23 | 109 |
|
GeneAware™ Expanded Panel (Female) Baylor Genetics United States | 1 | 422 |
|
GeneAware™ Expanded Panel (Male) Baylor Genetics United States | 1 | 382 |
|
GeneAware™ Expanded Plus Panel (Female) Baylor Genetics United States | 1 | 446 |
|
GeneAware™ Expanded Plus Panel (Male) Baylor Genetics United States | 1 | 401 |
|
Comprehensive Hearing Loss + mtDNA MNG Laboratories (Medical Neurogenetics, LLC.) United States | 218 | 300 |
|
CGC Genetics Unilabs Portugal | 1 | 203 |
|
CGC Genetics Unilabs Portugal | 1 | 306 |
|
Diseases of the posterior ocular segment (WES based NGS panel of 307 gene, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 307 |
|
CGC Genetics Unilabs Portugal | 1 | 1307 |
|
Síndrome de Usher (WES based NGS panel of 13 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 13 |
|
Deafness or hypoacusis panel_v.2.0 CGC Genetics Unilabs Portugal | 1 | 272 |
|
Usher syndrome type IJ (sequence analysis of CIB2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Deafness, autosomal recessive 48 (sequence analysis of CIB2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Targeted Variant, Fetal Analysis Integrated Genetics Westborough LabCorp United States | 292 | 746 |
|
Integrated Genetics Westborough LabCorp United States | 287 | 578 |
|
Integrated Genetics Westborough LabCorp United States | 292 | 597 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.